A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

Parravicini, A.

Paper Title Page
C-02 Commissioning of the CNAO LEBT and Sources 247
 
  • A. Parravicini, S. Alpegiani, G. Balbinot, G. Bazzano, D. Bianculli, J. Bosser, E. Bressi, G. Burato, G. Butella, M. Caldara, E. Chiesa, L. Falbo, A. Ferrari, F. Generani, F. Gerardi, L. Lanzavecchia, R. Monferrato, V. Mutti, M. Nodari, M. Pezzetta, A. Portalupi, C. Priano, M. Pullia, S. Rossi, M. Scotti, M. Spairani, E. Vacchieri, S. Vitulli
    CNAO, Milano
  • A. Reiter, B. Schlitt
    GSI, Darmstadt
  • C. Biscari, C. Sanelli
    INFN/LNF, Frascati
  • C. Roncolato
    INFN/LNL, Legnaro
  • L. Celona, G. Ciavola, S. Gammino, F. Maimone
    INFN/LNS, Catania
  • L. Frosini, G. Venchi
    University of Pavia, Pavia
  • M. Ferrarini
    Politecnico di Milano, Milano
  
 

The Cen­tro Nazionale di Adroter­apia On­co­log­i­ca (CNAO) is the Ital­ian cen­tre for deep hadron­ther­a­py, name­ly an in­no­va­tive type of ra­dio­ther­a­py using hadrons. The wide range of beam pa­ram­e­ters (i.e., en­er­gy and in­ten­si­ty) at pa­tient level to­geth­er with the ad­van­tages of hadron-ther­a­py with re­spect to tra­di­tion­al ra­dio-ther­a­py nour­ish­es the hopes for more ef­fec­tive pa­tient re­cov­ery. After the LEBT and the RFQ com­mis­sion­ing, the IH com­mis­sion­ing is now in progress. First pa­tients are ex­pect­ed to be treat­ed in 2010. The pre­sent paper sum­ma­rizes and eval­u­ates the Low En­er­gy Beam Trans­fer (LEBT) line com­mis­sion­ing, which has been car­ried out be­tween July 2008 and Jan­uary 2009.

  
C-03 Beam Diagnostics in the CNAO Injection Lines Commissioning 251
 
  • A. Parravicini, G. Balbinot, J. Bosser, E. Bressi, M. Caldara, L. Lanzavecchia, M. Pullia, M. Spairani
    CNAO, Milano
  • C. Biscari
    INFN/LNF, Frascati
  
 

The Cen­tro Nazionale di Adroter­apia On­co­log­i­ca (CNAO) is the first Ital­ian cen­ter for deep hadron­ther­a­py, name­ly an in­no­va­tive type of on­co­log­i­cal ra­dio­ther­a­py using hadrons. The CNAO ma­chine in­stal­la­tion is in progress and al­ter­nates with lines com­mis­sion­ing, start­ed in the Sum­mer 2008. The pre­sent paper re­ports about Beam Di­ag­nos­tics (BD) choic­es, sta­tus and post-com­mis­sion­ing eval­u­a­tion, as con­cerns the Low En­er­gy Beam Trans­fer (LEBT) line mon­i­tors.

  
TH-10 Status of Linac Beam Commissioning for the Italian Hadron Therapy Center CNAO 188
 
  • P. A. Posocco, A. Pisent, C. Roncolato
    INFN/LNL, Legnaro
  • G. Clemente, K.M. Kleffner, M. Maier, A. Reiter, B. Schlitt, H. Vormann
    GSI, Darmstadt
  • G. Balbinot, E. Bressi, M. Caldara, A. Parravicini, M. Pullia, E. Vacchieri, S. Vitulli
    CNAO, Milan
  • C. Biscari
    INFN/LNF, Frascati
  • L. Celona, G. Ciavola, S. Gammino
    INFN/LNS, Catania
  
 

The CNAO (Cen­tro Nazionale di Adroter­apia On­co­log­i­ca), lo­cat­ed in Pavia (Italy), is a ded­i­cat­ed clin­i­cal syn­chrotron fa­cil­i­ty for can­cer ther­a­py using high en­er­gy pro­ton and Car­bon beams. The 400 MeV/u syn­chrotron is in­ject­ed by a 216.8 MHz 7 MeV/u linac com­posed by a low en­er­gy beam trans­port (fed by two ion sources), a 400 keV/u 4-rod type RFQ and a 20 MV IHDTL. The com­mis­sion­ing of the two ECRIS ion sources and the low-en­er­gy line was suc­cess­ful­ly com­plet­ed at the end of Jan­uary 2009 reach­ing the prop­er beam con­di­tions for in­jec­tion into the RFQ. After in­stal­la­tion and con­di­tion­ing, the RFQ was com­mis­sioned with beam by the GSI-CNAO-INFN team in March 2009. The beam tests re­sults are pre­sent­ed and com­pared to the de­sign pa­ram­e­ters.

  

slides icon

Slides